Cisplatin, doxorubicin and cyclophosphamide (PAC) followed by radiation therapy in high-risk endometrial carcinoma

International Journal of Gynecological Cancer

Volumn 8, Issue 5, 1998, Pages 397-402

  Gabriele, A ^a,b   Lissoni, A ^a   Cormio, G ^a   Zanetta, G ^a   Colombo, A ^a   Pasta, F ^a   Landoni, F ^a  

^a SAN GERARDO HOSPITAL   (Italy)

^b NONE   (Italy)

Author keywords

Chemotherapy; Endometrial carcinoma; Radiation therapy

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BEAM THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; DRUG EFFECT; DRUG TOLERANCE; ENDOMETRIUM CANCER; FEMALE; HIGH RISK POPULATION; HUMAN; MULTIMODALITY CANCER THERAPY; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031741332     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1998.09857.x     Document Type: Article

References (17)

1. Creasman WT. Endometrial cancer: Incidence, prognostic factors, diagnosis, and treatment. Semin Oncol 1997; 24 (Suppl 1): 140-50.
2. Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma. Obstet Gynecol 1980; 56: 419-27.
3. Ackerman I, Malone S, Thomas G, Franssen E, Balogh J, Dembo A. Endometrial carcinoma-relative effectiveness of adjuvant irradiation vs therapy reserved for relapse. Gynecol Oncol 1996; 60: 177-83.
4. Moore TD, Philips PH, Nerenstone SR, Cheson BD. Systemic treatment of advanced and recurrent endometrial carcinoma: Current status and future directions. J Clin Oncol 1991; 9: 1071-88.
5. Muggia FM, Chia G, Reed LJ, et al. Doxorubicin-Cyclophosphamide: Effective chemotherapy for advanced endometrial carcinoma. Am J Obstet Gynecol 1977; 128: 314-9.
6. Stringer CA, Gershenson DM, Burke TW, Edwards CL, Gordon AN, Wharton JT. Adjuvant chemotherapy with Cisplatin, Doxorubicin, and Cyclophosphamide (PAC) for early stage high risk endometrial cancer: A preliminary analysis. Gynecol Oncol 1990; 38: 305-8.
7. Burke TW, Gereshenson DM, Morris M, Stringer CA, Levenback C, Tortolero Luna G, Backer W. Postoperative adjuvant Cisplatin, Doxorubicin, and Cyclophosphamide (PAC) chemotherapy in women with high-risk endometrial carcinoma. Gynecol Oncol 1994; 55: 47-50.
8. Morrow CP, Bundy BN, Homesley HD, Creasman WT, Hornback NB, Kurman R, Thigpen JT. Doxorubicin as an adjuvant following surgery and radiation therapy in patients with high-risk endometrial carcinoma, stage I and occult stage II: A Gynecologic Oncology Group Study. Gynecol Oncol 1990; 36: 166-71.
9. Schorge JO, Molpus KL, Goodman A, Nikrui N, Fuller AF. The effect of postsurgical therapy on stage III endometrial carcinoma. Gynecol Oncol 1996; 63: 34-9.
10. Reisinger SA, Asbury R, Liao SY, Homesley HD. A phase I study of weekly Cisplatin and whole abdominal radiation for the treatment of stage III and IV endometrial carcinoma: A Gynecologic Oncology Group pilot study. Gynecol Oncol 1996; 63: 299-303.
11. Onda T, Yoshikawa H, Mizutani K, Yokota H, Nagano H, Ozaki Y, Murakami A, Ueda K, Taketani Y. Treatment of node positive endometrial cancer with complete node dissection, chemotherapy and radiation therapy. Br J Cancer 1997; 75 (12): 1836-41.
12. Smith MR, Peters WA, III, Drescher CW. Cisplatin, Doxorubicin hydrochloride, and Cyclophosphamide followed by radiotherapy in high risk endometrial carcinoma. Am J Obstet Gynecol 1994; 170: 1677-82.
13. Creasman WT. New gynecologic cancer staging. Obstet Gynecol 1990; 75: 287-8.
14. Miller AB, Hoogstraten B, Staquet M, Winckler A. Reporting results of cancer treatment. Cancer 1981; 47: 207-14.
15. Neijt JP. Systemic treatment in disseminated endometrial cancer. Eur J Cancer 1993; 29: 628-32.
16. Cohen CJ. Advanced (FIGO stages III and IV) and recurrent carcinoma of the endometrium. In: Coppleson M, ed. Gynecologic Oncology (2nd ed). Edinburgh: Churchill Livingstone, 1992; 791-800.
17. Morrow CP, Bundy BN, Kurman RJ, Creasman WT, Heller P, Homesley HD, Graham JE. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: A Gynecologic Oncology Group study. Gynecol Oncol 1991; 40: 55-65.